Hydrops fetalis is defined as excessive fluid accumulation within at least two fetal extravascular compartments or body cavities. It is characterised by generalised skin thickening of more than 5 mm, placental enlargement, pericardial or pleural effusion and/or ascites.
INTRODUCTION
We aimed to study the profile of nonimmune hydrops fetalis (NIHF) in the local population and identify its outcomes and causes.
METHODS
We carried out a retrospective review of the medical records in KK Women's and Children's hospital, a single tertiary referral centre, for pregnancies with an antenatal diagnosis of NIHF in the six-year period from 1 January 2005 to 31 December 2010.
diagnosed with NIHF was a twin pregnancy. The median gestational age at diagnosis of NIHF was 27 (range 12-37) weeks.
The significant neonatal demographics are indicated in Table II A complete workup was done in 4 of the 9 cases without any known cause for NIHF. Of these 9 cases, 7 (78%) had normal chromosomes, 6 (67%) were negative for IUI; all were screened for thalassaemia and unremarkable cardiac findings were found in 6 (67%) mothers. For the remaining 20 cases with known aetiology, the common diagnoses were: (a) cardiac anomalies; (b) haematological problems, including homozygous alpha thalassaemia (Bart's hydrops), twin-to-twin transfusion syndrome (TTTS) and fetomaternal haemorrhage; (c) congenital tumours, including haemangioma and teratoma; and (d) cystic hygromas. Two cases had chromosomal disorder, one had a congenital disorder of glycosylation type 1a and one was diagnosed with Kabuki syndrome (Table III) .
There were a total of 19 live births, 1 intrauterine death, and 
D I SCU S S IO N
The number of conditions associated with NIHF is extensive.
In a recent systematic review of NIHF, Bellini et al found that cardiovascular causes were the most common (21.7%) aetiological factor. (1) According to these authors, chromosomal, syndromic and metabolic disorders collectively made up 18.9%
of NIHF cases, while haematological and TTTS-placental conditions comprised 16% of cases. (1) This is comparable with the results in our series, in which we found a majority of NIHF cases to be associated with cardiac anomalies (17%), haematological causes (14%) and genetic/metabolic disorders (14%). In our study, other important factors were congenital tumours (14%) and cystic hygromas (10%).
In our series, 2 of the 29 (7%) NIHF cases were caused by homozygous alpha-thalassaemia. Interestingly, this number is relatively low compared to that of other Asian countries.
For instance, in a ten-year review of hydrops fetalis at a hospital in Thailand, the most common known cause was Bart's hydrops fetalis (36.6%). (3) Similarly, a four-year series from a hospital in Taiwan also found the most common cause of NIHF to be Bart's hydrops fetalis (31%). (4) As the gene prevalence of thalassaemia in our local population is relatively high at approximately 3%, nationwide antenatal screening for thalassaemia is implemented. (5) Since the introduction of routine thalassaemia screening, the number of beta-thalassaemia major and homozygous alpha-thalassaemia births in Singapore has decreased dramatically. (6) This probably contributed to the lower numbers of Bart's hydrops fetalis found in our study compared to those from neighbouring countries.
Knowledge of the aetiology of a condition implies a better understanding of the underlying pathophysiology, which enables improved prevention and management strategies to be instituted. However, there remains a large number of NIHF cases for which the cause remains unknown. In our study, almost one-third of the NIHF cases had no identified aetiology. The review by Bellini et al found 17.8% of all cases reviewed to be idiopathic, (1) while another recent review by Abrams et al, which consisted of 598 NIHF cases from a large national database, found that the aetiology in 26.3% of cases were unidentified. (7) In the past, no cause was found in approximately 50% of NIHF cases. (2) However, with complete prenatal and postnatal evaluations, it is now suggested that a precise diagnosis can be arrived at in up to 85% of NIHF diagnoses. (2) Therefore, it is important to thoroughly investigate all NIHF cases so that common and known causes are not missed.
In our study, no case of NIHF was caused by congenital infection. However, only 17 of the 29 (59%) NIHF cases were investigated for IUI, and of the 9 cases in which the aetiology of NIHF was not identified, only 4 had a complete evaluation. Even in these four cases, the IUI workup was inconsistent. Thus, there is a need for a systematic and stepwise approach in NIHF investigations and diagnosis to ensure standardised evaluation of all cases.
As diagnostic and therapeutic strategies improve, it is hoped that the prognosis of NIHF will also improve. In our study, the neonatal mortality rate was almost 58%. The mortality rates in other centres range from 40% to 95%. (8) (9) (10) In the review by Abrams et al, the mortality rate was the highest among neonates with congenital anomalies (57.7%) and lowest among neonates with congenital chylothorax (5.9%). (7) According to
Stephenson et al, the mortality rate was lower if the hydrops was due to fetal supraventricular tachycardia (SVT) that responded to maternal treatment. (8) The only neonate with hydrops secondary to fetal SVT in our study survived.
Better techniques for antenatal screening have made the earlier detection of NIHF possible. In our series, the median gestational age at diagnosis of NIHF was 27 weeks. Antenatal identification of the aetiology of NIHF would allow for appropriate counselling of parents and help clinicians provide parents with early options such as medical termination of pregnancy, planned delivery or active antenatal treatment.
The median gestational age at birth was 33 weeks in our study. However, one should bear in mind that the decision on the timing of delivery should be jointly made by the obstetrician and neonatologist, as the risks of preterm delivery and hydrops should not be taken lightly. Furthermore, there have also been reported cases of spontaneous intrauterine resolution of fetal ascites and effusions. (11) We encountered two such cases of spontaneous resolution in our study; these neonates required no active resuscitation at birth.
As this was a retrospective study, it was limited by incomplete data. As mentioned earlier, investigations were inconsistently performed in the cases diagnosed with NIHF in our cohort. We were unable to obtain information on the severity of prenatal presentation or intervention. There was also no information on the long-term outcome of infants who survived. Apart from this, the number of cases diagnosed with NIHF at our hospital over the six-year study period was low. Larger prospective studies that assess the long-term neurodevelopmental outcome of NIHF are therefore warranted.
Systematic guidelines for the investigation of NIHF cases should also be put in place to ensure a comprehensive search of its aetiology.
In our series, almost one-third of cases antenatally diagnosed with NIHF had no identified aetiology, and the neonatal mortality rate was found to be approximately 58%.
Our findings highlight the importance of thorough investigation of all cases of NIHF to identify its causes, so that appropriate counselling and better management can be ensured for affected parents, both antenatally and postnatally.
